SCHEMBL13007331

SCHEMBL13007331

C=CCOc1c(OC)ccc2c(=O)n(C)ccc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 1/20 0.58
MTNR1B P49286 1/20 0.58
CNR2 P34972 2/20 0.43
KDM5A P29375 1/20 0.41
KDM5C P41229 1/20 0.41
TP53 P04637 3/20 0.39
POLB P06746 2/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
MAPT P10636 2/20 0.39
ALDH1A1 P00352 2/20 0.39
HPGD P15428 2/20 0.39
KDM4E B2RXH2 5/20 0.38
PDE4B Q07343 2/20 0.38
LMNA P02545 3/20 0.38
PTGS1 P23219 1/20 0.38
PTGS2 P35354 1/20 0.38
CYP2C9 P11712 1/20 0.38
NPC1 O15118 1/20 0.37
HSP90AA1 P07900 1/20 0.37
HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13061402 0.80 CNR2 (0.59) MTNR1AMTNR1BCNR2TP53POLB
SCHEMBL13007327 0.78 MTNR1A (0.77) MTNR1AMTNR1BCNR2TP53MAPT
SCHEMBL13007345 0.76 MTNR1B (0.81) MTNR1AMTNR1BCNR2TP53POLB
SCHEMBL13007341 0.73 MTNR1A (1.00) MTNR1AMTNR1BCNR2TP53POLB
SCHEMBL3783034 0.71 MTNR1A (0.48) MTNR1AMTNR1BCNR2KDM5CTP53
SCHEMBL28322540 0.68 ALDH1A1 (0.50) TP53POLBSMN1; SMN2MAPTALDH1A1
SCHEMBL17832018 0.68 SMN1; SMN2 (0.59) KDM5AKDM5CPOLBSMN1; SMN2ALDH1A1
SCHEMBL3771039 0.68 MTNR1A (0.45) MTNR1AMTNR1BCNR2TP53MAPT
SCHEMBL14106258 0.68 MTNR1A (0.45) MTNR1AMTNR1BCNR2TP53POLB
SCHEMBL9394915 0.67 GAA (0.53) MTNR1AMTNR1BTP53POLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8389544-B2 Isoquinolone compounds as subtype-selective agonists for melatonin receptors MT1 and MT2 THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2013-03-05 US disclosed
US-8389544-B2 Isoquinolone compounds as subtype-selective agonists for melatonin receptors MT1 and MT2 THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2013-03-05 US disclosed
US-20100317691-A1 ISOQUINOLONE COMPOUNDS AS SUBTYPE-SELECTIVE AGONISTS FOR MELATONIN RECEPTORS MT1 AND MT2 THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2010-12-16 US disclosed
US-20100317691-A1 ISOQUINOLONE COMPOUNDS AS SUBTYPE-SELECTIVE AGONISTS FOR MELATONIN RECEPTORS MT1 AND MT2 THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2010-12-16 US disclosed
WO-2008092292-A1 ISOQUINOLONE COMPOUNDS AS SUBTYPE-SELECTIVE AGONISTS FOR MELATONIN RECEPTORS MT1 AND MT2 THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2008-08-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317691-A1 ISOQUINOLONE COMPOUNDS AS SUBTYPE-SELECTIVE AGONISTS FOR MELATONIN RECEPTORS MT1 AND MT2 MTNR1A, MTNR1B, MC2R MTNR1A 1/4885MTNR1B 2/4885CNR2 37/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.